Reasons to Add STE Stock to Your Portfolio Right Now
STERIS' strong Healthcare growth, improving AST prospects and rising Life Sciences demand bolster its outlook, despite tariff and inflationary pressures.
Steris to Acquire Xodus Medical for $2.1 Billion
The Dublin, Ireland provider of products and services to hospitals and pharmaceutical manufacturers said it expects the deal to expand its portfolio.
STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?
STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.
Should Investors Buy STERIS as Growth Meets Reasonable Valuation?
STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.
STERIS Q1 Earnings Call Highlights
STERIS NYSE: STE reported first-quarter fiscal 2027 revenue growth and higher earnings, while maintaining its full-year outlook and outlining a $600 million investment in a new chemistry manufacturing, research and distribution complex in North Carolina.
STERIS plc (STE) Q1 2027 Earnings Call Transcript
STERIS plc (STE) Q1 2027 Earnings Call Transcript
STE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket Trading
STERIS beats fiscal Q1 earnings estimates as sales rise 7.3%, but a modest revenue miss sends shares 2.4% lower after hours.
Here's What Key Metrics Tell Us About Steris (STE) Q1 Earnings
While the top- and bottom-line numbers for Steris (STE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Steris (STE) Q1 Earnings Surpass Estimates
Steris (STE) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.54 per share. This compares to earnings of $2.34 per share a year ago.
Steris to invest $600 million in new North Carolina chemicals manufacturing hub
Medical equipment maker Steris said on Wednesday it will invest $600 million to build a manufacturing and distribution hub in North Carolina for chemicals used by healthcare and pharmaceutical customers.
STERIS' Q1 Earnings on Deck: What's in Store for the Stock?
STE is expected to deliver fiscal first-quarter revenue and EPS growth, driven by strength in Healthcare, continued momentum in AST, and healthy demand in Life Sciences.
